Cargando…

Symptom report in detecting breast cancer-related lymphedema

Breast cancer-related lymphedema is a syndrome of abnormal swelling coupled with multiple symptoms resulting from obstruction or disruption of the lymphatic system associated with cancer treatment. Research has demonstrated that with increased number of symptoms reported, breast cancer survivors’ li...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Mei R, Axelrod, Deborah, Cleland, Charles M, Qiu, Zeyuan, Guth, Amber A, Kleinman, Robin, Scagliola, Joan, Haber, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621182/
https://www.ncbi.nlm.nih.gov/pubmed/26527899
http://dx.doi.org/10.2147/BCTT.S87854
_version_ 1782397397444329472
author Fu, Mei R
Axelrod, Deborah
Cleland, Charles M
Qiu, Zeyuan
Guth, Amber A
Kleinman, Robin
Scagliola, Joan
Haber, Judith
author_facet Fu, Mei R
Axelrod, Deborah
Cleland, Charles M
Qiu, Zeyuan
Guth, Amber A
Kleinman, Robin
Scagliola, Joan
Haber, Judith
author_sort Fu, Mei R
collection PubMed
description Breast cancer-related lymphedema is a syndrome of abnormal swelling coupled with multiple symptoms resulting from obstruction or disruption of the lymphatic system associated with cancer treatment. Research has demonstrated that with increased number of symptoms reported, breast cancer survivors’ limb volume increased. Lymphedema symptoms in the affected limb may indicate a latent stage of lymphedema in which changes cannot be detected by objective measures. The latent stage of lymphedema may exist months or years before overt swelling occurs. Symptom report may play an important role in detecting lymphedema in clinical practice. The purposes of this study were to: 1) examine the validity, sensitivity, and specificity of symptoms for detecting breast cancer-related lymphedema and 2) determine the best clinical cutoff point for the count of symptoms that maximized the sum of sensitivity and specificity. Data were collected from 250 women, including healthy female adults, breast cancer survivors with lymphedema, and those at risk for lymphedema. Lymphedema symptoms were assessed using a reliable and valid instrument. Validity, sensitivity, and specificity were evaluated using logistic regression, analysis of variance, and areas under receiver operating characteristic curves. Count of lymphedema symptoms was able to differentiate healthy adults from breast cancer survivors with lymphedema and those at risk for lymphedema. A diagnostic cutoff of three symptoms discriminated breast cancer survivors with lymphedema from healthy women with a sensitivity of 94% and a specificity of 97% (area under the curve =0.98). A diagnostic cutoff of nine symptoms discriminated at-risk survivors from survivors with lymphedema with a sensitivity of 64% and a specificity of 80% (area under the curve =0.72). In the absence of objective measurements capable of detecting latent stages of lymphedema, count of symptoms may be a cost-effective initial screening tool for detecting lymphedema.
format Online
Article
Text
id pubmed-4621182
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-46211822015-11-02 Symptom report in detecting breast cancer-related lymphedema Fu, Mei R Axelrod, Deborah Cleland, Charles M Qiu, Zeyuan Guth, Amber A Kleinman, Robin Scagliola, Joan Haber, Judith Breast Cancer (Dove Med Press) Original Research Breast cancer-related lymphedema is a syndrome of abnormal swelling coupled with multiple symptoms resulting from obstruction or disruption of the lymphatic system associated with cancer treatment. Research has demonstrated that with increased number of symptoms reported, breast cancer survivors’ limb volume increased. Lymphedema symptoms in the affected limb may indicate a latent stage of lymphedema in which changes cannot be detected by objective measures. The latent stage of lymphedema may exist months or years before overt swelling occurs. Symptom report may play an important role in detecting lymphedema in clinical practice. The purposes of this study were to: 1) examine the validity, sensitivity, and specificity of symptoms for detecting breast cancer-related lymphedema and 2) determine the best clinical cutoff point for the count of symptoms that maximized the sum of sensitivity and specificity. Data were collected from 250 women, including healthy female adults, breast cancer survivors with lymphedema, and those at risk for lymphedema. Lymphedema symptoms were assessed using a reliable and valid instrument. Validity, sensitivity, and specificity were evaluated using logistic regression, analysis of variance, and areas under receiver operating characteristic curves. Count of lymphedema symptoms was able to differentiate healthy adults from breast cancer survivors with lymphedema and those at risk for lymphedema. A diagnostic cutoff of three symptoms discriminated breast cancer survivors with lymphedema from healthy women with a sensitivity of 94% and a specificity of 97% (area under the curve =0.98). A diagnostic cutoff of nine symptoms discriminated at-risk survivors from survivors with lymphedema with a sensitivity of 64% and a specificity of 80% (area under the curve =0.72). In the absence of objective measurements capable of detecting latent stages of lymphedema, count of symptoms may be a cost-effective initial screening tool for detecting lymphedema. Dove Medical Press 2015-10-15 /pmc/articles/PMC4621182/ /pubmed/26527899 http://dx.doi.org/10.2147/BCTT.S87854 Text en © 2015 Fu et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Fu, Mei R
Axelrod, Deborah
Cleland, Charles M
Qiu, Zeyuan
Guth, Amber A
Kleinman, Robin
Scagliola, Joan
Haber, Judith
Symptom report in detecting breast cancer-related lymphedema
title Symptom report in detecting breast cancer-related lymphedema
title_full Symptom report in detecting breast cancer-related lymphedema
title_fullStr Symptom report in detecting breast cancer-related lymphedema
title_full_unstemmed Symptom report in detecting breast cancer-related lymphedema
title_short Symptom report in detecting breast cancer-related lymphedema
title_sort symptom report in detecting breast cancer-related lymphedema
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621182/
https://www.ncbi.nlm.nih.gov/pubmed/26527899
http://dx.doi.org/10.2147/BCTT.S87854
work_keys_str_mv AT fumeir symptomreportindetectingbreastcancerrelatedlymphedema
AT axelroddeborah symptomreportindetectingbreastcancerrelatedlymphedema
AT clelandcharlesm symptomreportindetectingbreastcancerrelatedlymphedema
AT qiuzeyuan symptomreportindetectingbreastcancerrelatedlymphedema
AT guthambera symptomreportindetectingbreastcancerrelatedlymphedema
AT kleinmanrobin symptomreportindetectingbreastcancerrelatedlymphedema
AT scagliolajoan symptomreportindetectingbreastcancerrelatedlymphedema
AT haberjudith symptomreportindetectingbreastcancerrelatedlymphedema